REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Apteka N 155 (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Apteka N 155 Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

MUP Apteka N 155 is a company in Russia, with a head office in Shuya. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on November 10, 1996. There was a net sales revenue drop of 19.03% reported in MUP Apteka N 155’s latest financial highlights for 2023. Its total assets decreased by 33.66% over the same period. The net profit margin of MUP Apteka N 155 decreased by 3.68% in 2023.

Headquarters
Yuzhnaya 2-Ya, 4
Shuya; Ivanovo Oblast; Postal Code: 155908

Contact Details: Purchase the MUP Apteka N 155 report to view the information.

Basic Information
Outstanding Shares:
Purchase the MUP Apteka N 155 report to view the information.
Registered Capital:
Purchase the MUP Apteka N 155 report to view the information.
Incorporation Date:
November 10, 1996
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MUP Apteka N 155 report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-19.03%
Total operating revenue
-19.03%
Operating profit (EBIT)
-60.63%
Net Profit (Loss) for the Period
-363.25%
Total assets
-33.66%
Total equity
-51.75%
Operating Profit Margin (ROS)
-5.17%
Net Profit Margin
-3.68%
Return on Equity (ROE)
-96.08%
Quick Ratio
0.07%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?